Evidera
Andres Felipe Osorio Muriel is a highly experienced professional in the fields of health economics, modeling, and simulation, currently serving as a Research Associate at Evidera since April 2023. Previously, there was a significant tenure at Universidad Icesi from January 2011 to April 2023 as a full-time professor in the Departamento de Ingeniería Industrial. Andres also held the position of Director of the Master's program in Industrial Engineering at Pontificia Universidad Javeriana Cali in 2010, alongside teaching operations engineering as a part-time professor. Prior to these academic roles, experience included working at Coomeva as a Process and Productivity Analyst from September 2005 to August 2010. Educational qualifications include a PhD in Management Sciences from the University of Southampton, a Master's in Industrial Engineering, Logistics, and Operations Research from Universidad del Valle, and a Bachelor's degree in Industrial Engineering from the same institution.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.